Literature DB >> 9802796

Correlation of prostaglandin E2 production and gastric acid secretion in infants with hypertrophic pyloric stenosis.

K Shinohara1, T Shimizu, J Igarashi, Y Yamashiro, T Miyano.   

Abstract

PURPOSE: The aim of this study was to evaluate the relationship between gastric acid secretion and prostaglandin E2 (PGE2) generation in gastric mucosa and the role of PGE2 in the pathogenesis of hypertrophic pyloric stenosis (HPS).
METHODS: The authors measured the levels of PGE2 and gastric acidity in the gastric juice of HPS patients before and after a Ramstedt operation.
RESULTS: The PGE2 concentration in the gastric juice of nine HPS patients before the Ramstedt operation was significantly higher than that of eight controls, and the concentration significantly decreased after the operation. A significant inverse correlation between the PGE2 concentration and the pH level in the gastric juice was shown in HPS patients before and after the operation.
CONCLUSION: These results suggest that the enhanced generation of PGE2 in gastric mucosa in cases of HPS is a secondary phenomenon caused by hyperacidity and is not responsible for the pathogenesis of HPS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9802796     DOI: 10.1016/s0022-3468(98)90480-8

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  5 in total

1.  Transient hypertrophic pyloric stenosis due to prostoglandin infusion.

Authors:  T Soyer; S Yalcin; D Bozkaya; S Yiğit; F C Tanyel
Journal:  J Perinatol       Date:  2014-10       Impact factor: 2.521

Review 2.  The association of erythromycin and infantile hypertrophic pyloric stenosis: causal or coincidental?

Authors:  Manfred Hauben; Guy W Amsden
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 3.  New insights into the pathogenesis of infantile pyloric stenosis.

Authors:  Christina Panteli
Journal:  Pediatr Surg Int       Date:  2009-09-16       Impact factor: 1.827

4.  Association of prematurity with the development of infantile hypertrophic pyloric stenosis.

Authors:  Christopher M Stark; Philip L Rogers; Matthew D Eberly; Cade M Nylund
Journal:  Pediatr Res       Date:  2015-05-07       Impact factor: 3.756

5.  Prolonged prostaglandin E1 therapy in a neonate with pulmonary atresia and ventricular septal defect and the development of antral foveolar hyperplasia and hypertrophic pyloric stenosis.

Authors:  Tina Perme; Senja Mali; Ivan Vidmar; Diana Gvardijančič; Robert Blumauer; David Mishaly; Iztok Grabnar; Gregor Nemec; Stefan Grosek
Journal:  Ups J Med Sci       Date:  2013-03-22       Impact factor: 2.384

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.